Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

This study is currently recruiting participants.

Study NCT00667121 Information provided by National Cancer Institute (NCI)

First Received: April 24, 2008 Last Updated: August 4, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)